Prostate cancer is most commonly diagnosed cancer across UK, study finds

"Prostate cancer is now the most commonly diagnosed form of cancer across the UK, surpassing breast cancer, according to a leading charity. There were 64,425 diagnoses of prostate cancer in 2022, an analysis of NHS figures by Prostate Cancer UK found, and 61,640 new cases of breast cancer. The analysis found there to be a discrepancy at which stage men with prostate cancer were diagnosed, with 31% of men in Scotland diagnosed with prostate cancer at stage 4, compared with 21% of men in England."

"About one in eight men across the UK will be affected by prostate cancer in their lifetimes, with approximately 12,200 deaths each year caused by the disease. One in four black men will be diagnosed with prostate cancer in their lifetimes. They also have a higher risk of a late-stage diagnosis compared with their white counterparts. Prostate Cancer UK highlighted the apparent postcode lottery with regard to testing and diagnoses of the disease."

"risk awareness campaigns had played a big part in the overall increase, which had led to more men than ever being diagnosed and treated. Prostate cancer is now the most common cancer in the UK, but despite this, men are facing deeply unfair inequities across the country, and their experiences vary hugely based on where they live, De Biase said. We urgently need an early detection programme that will address these regional inequities."

Prostate cancer overtook breast cancer as the most commonly diagnosed cancer in the UK in 2022, with 64,425 diagnoses versus 61,640 breast cancer cases. Diagnosis stage varied regionally, with 31% of Scottish men diagnosed at stage 4 compared with 21% in England. About one in eight men will develop prostate cancer, with roughly 12,200 deaths each year. One in four Black men will be diagnosed and face higher risk of late-stage diagnosis than white men. PSA testing rates are highest in south‑east England and lowest in the north‑west. Men in deprived areas are 29% more likely to have cancer that has spread at diagnosis. Experts call for an early detection programme to address regional inequities.

Read at www.theguardian.com